Pharma
- INDIAINDIA · 1 min
Fosun Pharma sells 4.55% stake in Gland Pharma for Rs 2,121 crore
Fosun Pharma sold a 4.55% stake in Gland Pharma for Rs 2,121 crore, according to thehindubusinessline.com.
05 Sept, 11:28 pm IST - INDIAINDIA · 1 min
Natco Pharma shifts focus from generics to new growth strategies
Natco Pharma is moving beyond its traditional generics business as competition intensifies and growth in that sector slows, CEO Rajeev Nannapaneni said in an interview published on September 1.
01 Sept, 07:28 am IST - STARTUPSSTARTUPS · 2 min
Honasa calls off ₹135 crore Fluence Pharma acquisition over unmet conditions
Honasa Consumer, the parent company of Mamaearth, has called off its proposed ₹135 crore acquisition of a 58% stake in nutraceuticals startup Fluence Pharm…
26 Aug, 11:28 am IST - INDIAINDIA · 2 min
Gland Pharma Q1 net profit rises 47% to ₹317 crore
Gland Pharma reported a 47% year-on-year increase in consolidated net profit to ₹317 crore for the first quarter, despite a 14% sequential decline, the company announced on August 10.
10 Aug, 05:28 pm IST - INDIAINDIA · 2 min
Sun Pharma misses Q1 estimates as US generics drag profits
Sun Pharmaceutical Industries, India's largest drugmaker by market capitalization, reported consolidated revenue of ₹15,299 crore for the June quarter, marking a 10.5% year-on-year increase.
31 Jul, 05:28 pm IST - FUNDINGFUNDING · 2 min
Honasa acquires 58% stake in Fluence Pharma for Rs 135 crore
Honasa Consumer, the parent company of Mamaearth, has acquired a 58% stake in Mumbai-based Fluence Pharma Private Limited at an enterprise value of approximately Rs 135 crore.
25 Jun, 04:08 pm IST - FUNDINGFUNDING · 2 min
Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135 crore valuation
Honasa Consumer is set to acquire a majority stake in hair therapy brand Fluence Pharma at a valuation of Rs 135 crore, according to economictimes.indiatimes.com.
23 Jun, 08:08 pm IST - FUNDINGFUNDING · 1 min
SBI to provide $1 billion funding for Sun Pharma’s Organon acquisition
State Bank of India (SBI) is set to commit up to $1 billion to support Sun Pharmaceutical Industries Ltd.’s $12 billion acquisition of US-listed Organon & Co., according to livemint.com.
09 Jun, 06:08 pm IST - FUNDINGFUNDING · 2 min
Exclusive: Perceptic, a startup automating drug discovery end-to-end for Big Pharma, emerges from stealth with $12 million in seed funding
Perceptic, a startup founded by former Palantir executives, has emerged from stealth with $12 million in seed funding to develop an end-to-end AI platform for drug development.
26 May, 09:24 pm IST